Financhill
Buy
58

CRVO Quote, Financials, Valuation and Earnings

Last price:
$14.50
Seasonality move :
9.13%
Day range:
$12.05 - $16.94
52-week range:
$1.80 - $25.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
168.72x
P/B ratio:
3.22x
Volume:
7.3M
Avg. volume:
8.9M
1-year change:
-35.39%
Market cap:
$126.4M
Revenue:
--
EPS (TTM):
-$2.03

Earnings Data

Next earnings date for CRVO
May 15
2025
Most recent earnings per share
-$0.80
Missed by $0.17
(Mar 17/2025)
Consensus Estimate
-$0.63
(Mar 17/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRVO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 $2M -- -- -$0.62 --
03/17/2025 Q4 $1.7M -- -$0.80 -$0.63 -$0.17
11/12/2024 Q3 $2.8M -- -$0.55 -$0.41 -$0.14
08/12/2024 Q2 $2.2M -- -$0.27 -$0.29 $0.02
05/15/2024 Q1 $2.4M -- -$0.41 -$0.32 -$0.09
12/31/2023 Q4 $1M -- -$0.42 -$0.29 -$0.13
11/13/2023 Q3 -- -- -$0.70 -- --
06/30/2023 Q2 -- -- -$1.56 -- --
03/31/2023 Q1 -- -- -$1.03 -- --
12/31/2022 Q4 -- -- -$2.95 -- --
09/30/2022 Q3 -- -- -$1.70 -- --
06/30/2022 Q2 -- -- -$3.09 -- --
03/31/2022 Q1 -- -- -$3.33 -- --
12/31/2021 Q4 -- -- -$2.43 -- --
09/30/2021 Q3 -- -- -$8.99 -- --
06/30/2021 Q2 -- -- -$2.78 -- --
03/31/2021 Q1 -- -- -$4.22 -- --
12/31/2020 Q4 -- -- -$4.50 -- --
09/30/2020 Q3 -- -- -$5.25 -- --
06/30/2020 Q2 -- -- -$7.50 -- --
03/31/2020 Q1 -- -- -$5.25 -- --
12/31/2019 Q4 -- -- -$8.41 -- --
09/30/2019 Q3 -- -- -$45.00 -- --
06/30/2019 Q2 -- -- -$47.25 -- --
03/31/2019 Q1 -- -- -$60.75 -- --
12/31/2018 Q4 -- -- -$120.00 -- --
09/30/2018 Q3 -- -- -$149.25 -- --
06/30/2018 Q2 -- -- -$61.50 -- --
03/31/2018 Q1 -- -- -$308.25 -- --
12/31/2017 Q4 -- -- -$124.51 -- --
09/30/2017 Q3 -- -- $225.00 -- --
06/30/2017 Q2 -- -- -$1,124.99 -- --
03/31/2017 Q1 -- -- -$3,127.48 -- --
12/31/2016 Q4 -- -- -$270.00 -- --
09/30/2016 Q3 -- -- -$596.25 -- --
06/30/2016 Q2 -- -- -$416.25 -- --
03/31/2016 Q1 -- -- -$697.50 -- --
12/31/2015 Q4 -- -- -$850.02 -- --
09/30/2015 Q3 -- -- -$720.00 -- --
06/30/2015 Q2 -- -- -$675.00 -- --
03/31/2015 Q1 -- -- -$675.00 -- --

CervoMed Earnings Questions

  • How Much did CervoMed Generate in Revenue Last Quarter?

    CervoMed reported -- worth of top line sales in its most recent quarter.

  • Did CervoMed Beat Earnings Last Quarter?

    CervoMed announced earnings per share of -$0.80 which represents a miss of analyst forecast a -$0.63 per share.

  • Is CervoMed Profitable?

    CervoMed reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CervoMed EPS Next Year?

    CervoMed's earnings are forecast to decrease from -$2.02 per share to -$1.85 per share next year representing a decrease of -1.4%.

  • When is CervoMed's Earnings Date?

    CervoMed's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock